AVEO Oncology
AVEO
#6581
Rank
โ‚ฌ0.49 B
Marketcap
14,24ย โ‚ฌ
Share price
0.00%
Change (1 day)
179.10%
Change (1 year)

Revenue for AVEO Oncology (AVEO)

Revenue in 2022 (TTM): โ‚ฌ89.52 Million

According to AVEO Oncology 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ89.57 Million. In 2021 the company made a revenue of โ‚ฌ37.34 Million an increase over the revenue in the year 2020 that were of โ‚ฌ4.89 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AVEO Oncology from 2009 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) โ‚ฌ89.52 M139.71%
2021 โ‚ฌ37.34 M663.18%
2020 โ‚ฌ4.89 M-80.96%
2019 โ‚ฌ25.7 M443.65%
2018 โ‚ฌ4.72 M-25.15%
2017 โ‚ฌ6.31 M164.18%
2016 โ‚ฌ2.39 M-86.26%
2015 โ‚ฌ17.39 M16.76%
2014 โ‚ฌ14.9 M1491.64%
2013 โ‚ฌ0.93 M-93.58%
2012 โ‚ฌ14.58 M-88.51%
2011 โ‚ฌ0.12 B277.88%
2010 โ‚ฌ33.59 M132.29%
2009 โ‚ฌ14.46 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ9.18 B 10,154.56%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ13.15 B 14,581.14%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ45.04 B 50,192.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ38.80 B 43,224.57%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ30.89 B 34,393.58%๐Ÿ‡บ๐Ÿ‡ธ USA